AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Cold Agglutinin Disease Market Spotlight 2019: Key Pipeline Drugs, Clinical Trials, Probability of Success, Licensing, Acquisition Deals, and Epidemiology - ResearchAndMarkets.com

November 5, 2019

DUBLIN--(BUSINESS WIRE)--Nov 5, 2019--

The “Market Spotlight: Cold Agglutinin Disease” report has been added to ResearchAndMarkets.com’s offering.

This Market Spotlight report covers the Cold Agglutinin Disease market, comprising disease background and treatment information, key pipeline drugs, clinical trials, probability of success, licensing and acquisition deals, and an epidemiology overview.

Key Takeaways

Key Topics Covered:

OVERVIEW

KEY TAKEAWAYS

DISEASE BACKGROUND

Disease definition

Patient subtypes

Symptoms

Risk factors

Diagnosis

TREATMENT

Non-pharmacological treatment

Pharmacological treatment

EPIDEMIOLOGY

PIPELINE DRUGS

PROBABILITY OF SUCCESS

LICENSING AND ASSET ACQUISITION DEALS

PARENT PATENTS

CLINICAL TRIAL LANDSCAPE

Sponsors by status

Sponsors by phase

BIBLIOGRAPHY

APPENDIX

For more information about this report visit https://www.researchandmarkets.com/r/njlzqh

View source version on businesswire.com:https://www.businesswire.com/news/home/20191105005510/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/05/2019 04:33 AM/DISC: 11/05/2019 04:33 AM

http://www.businesswire.com/news/home/20191105005510/en